everolimus in er-positive breast cancer
Published 12 years ago • 3.5K plays • Length 2:56Download video MP4
Download video MP3
Similar videos
-
10:55
san antonio roundtable, part 4: everolimus in clinical practice, a new cdk inhibitor
-
8:15
bolero-2: overcoming treatment resistance in breast cancer
-
3:07
breast cancer drug t-dm1 shows promise in trial
-
7:02
the ongoing role of everolimus in er-positive mbc
-
2:46
combo boosts breast cancer survival in bolero-2
-
3:16
dual her2 blockade defers breast cancer in cleopatra
-
5:50
anastrazole and fulvestrant in hormone receptor-positive breast cancer
-
7:37
next steps for everolimus in er-positive metastatic breast cancer
-
3:38
treating early breast cancer
-
7:26
s1222 hr , stage iv breast cancer: fulvestrant w/wo everolimus /- anastrozole
-
4:18
adjuvant et /- 1 year of everolimus in patients with high-risk hr-positive, her2-negative bc
-
3:56
role of everolimus in hr metastatic breast cancer
-
7:06
everolimus extends pfs for hr positive, her2 negative breast cancer
-
1:03
dr. carey on everolimus in metastatic breast cancer
-
9:15
sequencing and role of everolimus in hr-positive breast cancer
-
8:33
bolero-2 trial: everolimus in metastatic breast cancer
-
2:06
bolero-2 (afinitor and exemestane study) shows implications in er-positive breast cancer
-
2:41
everolimus for hr metastatic breast cancer
-
1:11
results of trial of ribociclib with everolimus and exemestane in breast cancer